Drug · DIN 02405415
RIZATRIPTAN ODT
No: cancelled before it was sold
Authorized, then cancelled before it was ever sold in Canada.
Status Cancelled Pre Market since September 12, 2017.
- Drug Identification Number (DIN)
- 02405415
- Company (DIN owner)
- Abri Pharmaceuticals IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet (Orally-Disintegrating)
- Route
- Oral
- Therapeutic class (ATC)
- Rizatriptan N02CC04
- Class
- Human
- Record last updated
- June 22, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| RIZATRIPTAN (RIZATRIPTAN BENZOATE) | 5 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- April 18, 2013: NOC 14296Abbreviated New Drug Submission (ANDS) · New manufacturer and product name
Other DINs named RIZATRIPTAN ODT
- DIN 02442906 · Marketed
- DIN 02442914 · Marketed
- DIN 02446111 · Marketed
- DIN 02446138 · Marketed
- DIN 02405423 · Cancelled Pre Market